Yellow dermatology: Highlighting its diagnostic and teaching challenge


  • Khalifa E. Sharquie Department of Dermatology, College of Medicine, University of Baghdad, Medical City Teaching Hospital, Baghdad, Iraq.
  • Raed I. Jabbar Department of Dermatology, Fallujah Teaching Hospital, Al-Anbar Health Directorate, Anbar, Iraq.
  • Robert A. Schwartz Department of Dermatology, Pediatrics, Medicine, and Pathology, Rutgers New Jersey Medical School, Newark, NJ, USA.


Lipid, Yellow, Pigment, Xanthoma


Objective There are many skin diseases that might present as yellowish skin lesions initially or during the course of the disease. The objective of the study is to record all patients that have yellowish rash during the progress of the disease and according to daily clinical practice and their importance in dermatology and general medicine.   Methods All patients that had yellowish skin rash during the course of the disease were enrolled during the period from February 2014 to March 2021.They were well-assessed and classified. Clinical photographs with some histopathological findings were recorded.   Results The following diseases were classified to have yellow skin rash initially or during the course of the disease and their frequencies were calculated, in addition to the medical importance to patients and dermatologists: 1- Histiocytosis- xanthogranuloma group. 2- Xanthoma groups. 3-Xanthomatous morphea. 4- Keratoderma. 5- Calcinosis cutis. 6- Systemic sclerosis. 7-Pseudoxanthoma elasticum. 8- Papular mucinosis. 9- Necrobiosis lipoidica. 10-Xanthomastocytoma. 11- Yellow nail syndrome. 12- Ecchymosis. 13-Nevus sebaceous. 14-Sebaceous hyperplasia. 15-Nevus anemicus. 16-Yellow teeth. In addition, anemia and jaundice usually present as generalized yellowish skin discoloration.   Conclusion Yellow dermatology is a group of diseases that characteristically presents with yellowish skin lesions initially or during the progression of the disease. They are well classified to be informative in medical practice and teaching sessions. The cause of this color is different according to the disease status as could be fat deposition, fat engulfing cells, connective tissue degeneration, sebaceous cells hyperplasia, hemoglobin and hemosiderin deposition, vasoconstriction, or unknown reason.  



Elliot AJ, Maier MA. Color psychology: effects of perceiving color on psychological functioning in humans. Annu Rev Psychol. 2014; 65:95-120.

Elliot AJ. Color and psychological functioning: a review of theoretical and empirical work. Front Psychol. 2015; 6:368.

Alfenas ER, da Silva J, Silveira MES, et al. A Painting Technique Using Ceramic Pigments for the Artificial Iris of an Ocular Prosthesis Guided by Applying Newton's Color Wheel. J Prosthodont. 2019 ;28(2): e822-e825.

Tseng S-H, Bargo P, Durkin A, et al. Chromophore concentrations, absorption and scattering properties of human skin in-vivo. Optics express. 2009; 17:14599-14617.

Nordlund JJ, Cestari T, Grimes P, et al. A more precise lexicon for pigmentation, pigmentary disorders, and "chromatic" abnormalities. In:Nordlund JJ, Boissy RE, Hearing VJ, et al eds: The Pigmentary System. 2nd ed. Malden, Mass: Blackwell Pub; 2006:499-503.

Henderson AJ, Lasselin J, Lekander M, et al. Skin colour changes during experimentally-induced sickness. Brain Behav Immun. 2017; 60:312-318.

Masuda Y, Ogura Y, Inagaki Y, et al. Analysis of the influence of collagen fibers in the dermis on skin optical reflectance by Monte Carlo simulation in a nine-layered skin model. Skin Res Technol. 2018; 24:248-255.

Ghosh SK, Bandyopadhyay D, Jamadar NS. Nevus lipomatosus cutaneous superficialis: An unusual presentation. Dermatol Online J. 2010; 16:12.

Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016; 127:2672-2681.

Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Jun;158(2):181-8. Epub 2014 Apr 29.

Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol. 2006; 18(6):606-13.

McLean WH. Genetic disorders of palm skin and nail. J Anat. 2003; 202:133-141.

Jiménez-Gallo D, Ossorio-García L, Linares-Barrios M. Calcinosis Cutis and Calciphylaxis. Actas Dermosifiliogr. 2015;106(10):785-94.

Boin F, Wigley FM. Clinical features and treatment of scleroderma In: Firestein GS, Budd RC, Gabriel SE, et al, editors Kelley’s Textbook of Rheumatology, 9th ed Philadelphia: Elsevier/Saunders; 2012 p 1366–403.

Li Q, van de Wetering K, Uitto J. Pseudoxanthoma Elasticum as a Paradigm of Heritable Ectopic Mineralization Disorders: Pathomechanisms and Treatment Development. Am J Pathol. 2019;198(2):216-225.

Kranenburg G, de Jong PA, Bartstra JW, et al. Etidronate for prevention of ectopic mineralization in patients with pseudoxanthoma elasticum. J Am Coll Cardiol. 2018; 71:1117-1126.

Sharquie K, Jabbar R I. Papular mucinosis (papular lichen myxedematosus): Clinical and histopathological evaluation. Our Dermatol Online. 2021;12(2):113-119.

Reid SD, Ladizinski B, Lee K, et al. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol 2013; 69: 783– 791.

Torrelo A, Alvarez‐Twose I, Escribano L. Childhood mastocytosis. Curr Opin Pediatr. 2012; 24: 480– 486.

Hayashi I, Abe R, Yanagi T, et al. Yellow nail syndrome: nail change reflects disease severity. J Dermatol .2012; 39: 415– 416.

Mosqueda L, Burnight K, Liao S. The life cycle of bruises in older adults. J Am Geriatr Soc. 2005; 53: 1339– 1343.

Moody MN, Landau JM, Goldberg LH. Nevus sebaceous revisited. Pediatr Dermatol. 2012; 29:15-23.

Arshad A M, D'angelis CA.Sebaceous Tumors of the Skin and Muir Torre Syndrome-A Mini-Review. N. A. J. Med. Sci.2014 ;7 (2): 87-92.

Bulteel C, Morren MA, De Haes P, Denayer E, Legius E, Brems H. Nevus anemicus and RASopathies. JAAD Case Rep. 2018;4(4):390-391.

Lynch CD, McConnell RJ. The use of microabrasion to remove discolored enamel: a clinical report. J Prosthet Dent. 2003;90(5):417-9.

Torrelo A, Alvarez‐Twose I, Escribano L. Childhood mastocytosis. Curr Opin Pediatr 2012; 24: 480– 486.

Valenzuela A, Chung L. Calcinosis: pathophysiology and management. Curr Opin Rheumatol. 2015; 27:542-548.

Solomon DH, Avorn J, Levin R, et al. Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis. 2008; 67:609-613.

Hayashi I, Abe R, Yanagi T, et al. Yellow nail syndrome: nail change reflects disease severity. J Dermatol. 2012; 39: 415– 416.

Lackner H,Karpatkin S. On the “easy bruising “syndrome with normal platelet count: a study of 75 patients. Ann Intern Med. 1975; 83:190-6.




How to Cite

Sharquie KE, Jabbar RI, Schwartz RA. Yellow dermatology: Highlighting its diagnostic and teaching challenge. J Pak Assoc Dermatol [Internet]. 2024Apr.21 [cited 2024May22];34(2):334-40. Available from:



Original Articles

Most read articles by the same author(s)